State Street Corp Boosts Holdings in Oscar Health, Inc. (NYSE:OSCR)

State Street Corp lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 6.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,132,802 shares of the company's stock after purchasing an additional 291,335 shares during the quarter. State Street Corp owned about 2.12% of Oscar Health worth $108,867,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Stifel Financial Corp increased its stake in Oscar Health by 14.3% during the 3rd quarter. Stifel Financial Corp now owns 151,589 shares of the company's stock valued at $3,215,000 after purchasing an additional 18,952 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Oscar Health by 30.3% during the third quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company's stock valued at $25,709,000 after acquiring an additional 281,858 shares in the last quarter. Parkman Healthcare Partners LLC purchased a new position in Oscar Health in the 3rd quarter worth approximately $5,302,000. Jacobs Levy Equity Management Inc. raised its holdings in Oscar Health by 2.2% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,263,672 shares of the company's stock worth $26,802,000 after acquiring an additional 27,088 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its position in Oscar Health by 27.1% in the 3rd quarter. Janus Henderson Group PLC now owns 72,236 shares of the company's stock valued at $1,532,000 after acquiring an additional 15,400 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Oscar Health Stock Up 1.7 %

Shares of OSCR stock traded up $0.23 during trading hours on Monday, reaching $13.89. 5,461,982 shares of the company's stock were exchanged, compared to its average volume of 3,473,683. Oscar Health, Inc. has a 1 year low of $7.67 and a 1 year high of $23.79. The stock has a market cap of $3.43 billion, a PE ratio of -231.46 and a beta of 1.63. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock's fifty day moving average price is $16.24 and its two-hundred day moving average price is $17.56.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same period in the prior year, the firm posted ($0.29) EPS. The business's revenue was up 68.3% compared to the same quarter last year. Research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on OSCR. Piper Sandler reissued an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Jefferies Financial Group began coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price on the stock. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, UBS Group initiated coverage on Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $21.56.

Insider Activity

In related news, COO Steven Wolin sold 19,580 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $354,006.40. Following the sale, the chief operating officer now directly owns 102,598 shares in the company, valued at approximately $1,854,971.84. The trade was a 16.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now directly owns 81,962 shares in the company, valued at $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.